CN101040981A - 一种内服治疗神经根型颈椎病的中药组合物

它是颈椎侧后方的突出物压迫或刺激颈神经根所引起。

其症状有疼痛，疼痛为绞痛、钝痛或灼痛，颈部功能障碍，影响工作或睡眠。

由于颈 ... CN101040981A-一种内服治疗神经根型颈椎病的中药组合物 -GooglePatents 一种内服治疗神经根型颈椎病的中药组合物 DownloadPDF Info Publicationnumber CN101040981A CN101040981A CNA2007100145570A CN200710014557A CN101040981A CN101040981A CN101040981A CN101040981A CNA2007100145570A CNA2007100145570A CNA2007100145570A CN200710014557A CN200710014557A CN200710014557A CN101040981A CN101040981A CN101040981A Authority CN China Priorartkeywords radix root pain spondyloticradiculopathy cervical Priorartdate 2007-04-19 Legalstatus(Thelegalstatusisanassumptionandisnotalegalconclusion.Googlehasnotperformedalegalanalysisandmakesnorepresentationastotheaccuracyofthestatuslisted.) Granted Applicationnumber CNA2007100145570A Otherlanguages English(en) Otherversions CN100594033C (zh Inventor 于春杰 徐恒雁 OriginalAssignee 于春杰 Prioritydate(Theprioritydateisanassumptionandisnotalegalconclusion.Googlehasnotperformedalegalanalysisandmakesnorepresentationastotheaccuracyofthedatelisted.) 2007-04-19 Filingdate 2007-04-19 Publicationdate 2007-09-26 2007-04-19 Applicationfiledby于春杰 filed Critical 于春杰 2007-04-19 PrioritytoCN200710014557A priority Critical patent/CN100594033C/zh 2007-09-26 PublicationofCN101040981A publication Critical patent/CN101040981A/zh 2010-03-17 Applicationgranted granted Critical 2010-03-17 PublicationofCN100594033C publication Critical patent/CN100594033C/zh Status Expired-FeeRelated legal-status Critical Current 2027-04-19 Anticipatedexpiration legal-status Critical Links Espacenet GlobalDossier Discuss 239000003814 drug Substances 0.000 title claims abstract description 17 206010037779 Radiculopathy Diseases 0.000 title claims description 18 150000001875 compounds Chemicalclass 0.000 title 1 239000000203 mixture Substances 0.000 claims description 9 241000903946 Clematidis Species 0.000 claims description 4 241000756943 Codonopsis Species 0.000 claims description 4 241001489978 Eupolyphaga Species 0.000 claims description 4 239000009636 HuangQi Substances 0.000 claims description 4 241000237636 Pheretima Species 0.000 claims description 4 239000002994 rawmaterial Substances 0.000 claims description 3 201000010099 disease Diseases 0.000 abstract description 8 XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3 210000003296 Saliva Anatomy 0.000 abstract description 2 241000213006 Angelicadahurica Species 0.000 abstract 2 229940107666 ASTRAGALUSROOT Drugs 0.000 abstract 1 241001671653 Aconitumcarmichaelii Species 0.000 abstract 1 240000004499 Cinnamomumaromaticum Species 0.000 abstract 1 235000014489 Cinnamomumaromaticum Nutrition 0.000 abstract 1 241001256368 Clematischinensis Species 0.000 abstract 1 241000234653 Cyperus Species 0.000 abstract 1 235000002848 Cyperusflabelliformis Nutrition 0.000 abstract 1 241000501743 Gentianamacrophylla Species 0.000 abstract 1 241000112528 Ligusticumstriatum Species 0.000 abstract 1 241000361919 Metaphiresieboldi Species 0.000 abstract 1 240000008259 Paeoniaofficinalis Species 0.000 abstract 1 235000006484 Paeoniaofficinalis Nutrition 0.000 abstract 1 244000046146 Puerarialobata Species 0.000 abstract 1 235000010575 Puerarialobata Nutrition 0.000 abstract 1 241000736246 Pyrola Species 0.000 abstract 1 235000018167 Reynoutriajaponica Nutrition 0.000 abstract 1 240000001341 Reynoutriajaponica Species 0.000 abstract 1 241000913745 Spatholobus Species 0.000 abstract 1 -1 asaryl Chemicalgroup 0.000 abstract 1 239000008194 pharmaceuticalcomposition Substances 0.000 abstract 1 239000002023 wood Substances 0.000 abstract 1 208000002193 Pain Diseases 0.000 description 33 230000036407 pain Effects 0.000 description 33 239000008280 blood Substances 0.000 description 16 210000004369 Blood Anatomy 0.000 description 15 208000006820 Arthralgia Diseases 0.000 description 12 210000004185 Liver Anatomy 0.000 description 12 230000000694 effects Effects 0.000 description 12 230000001737 promoting Effects 0.000 description 11 210000003734 Kidney Anatomy 0.000 description 10 230000017531 bloodcirculation Effects 0.000 description 10 210000003205 Muscles Anatomy 0.000 description 9 210000000988 BoneandBones Anatomy 0.000 description 8 238000002560 therapeuticprocedure Methods 0.000 description 6 206010001928 Amenorrhoea Diseases 0.000 description 5 206010072736 Rheumaticdisease Diseases 0.000 description 5 201000000736 amenorrhea Diseases 0.000 description 5 231100000540 amenorrhea Toxicity 0.000 description 5 210000001015 Abdomen Anatomy 0.000 description 4 206010019233 Headache Diseases 0.000 description 4 210000001624 Hip Anatomy 0.000 description 4 210000000952 Spleen Anatomy 0.000 description 4 231100000869 headache Toxicity 0.000 description 4 238000000034 method Methods 0.000 description 4 238000005728 strengthening Methods 0.000 description 4 230000002522 swelling Effects 0.000 description 4 206010003549 Asthenia Diseases 0.000 description 3 206010005963 Boneformationincreased Diseases 0.000 description 3 206010007247 Carbuncle Diseases 0.000 description 3 208000006111 Contracture Diseases 0.000 description 3 241000668709 Dipterocarpuscostatus Species 0.000 description 3 210000003414 Extremities Anatomy 0.000 description 3 210000003128 Head Anatomy 0.000 description 3 206010022114 Injury Diseases 0.000 description 3 210000003127 Knee Anatomy 0.000 description 3 206010027327 Menstrualdisease Diseases 0.000 description 3 206010062575 Musclecontracture Diseases 0.000 description 3 208000004880 Polyuria Diseases 0.000 description 3 206010037660 Pyrexia Diseases 0.000 description 3 206010068760 Ulcers Diseases 0.000 description 3 235000009508 confectionery Nutrition 0.000 description 3 238000006073 displacementreaction Methods 0.000 description 3 230000035619 diuresis Effects 0.000 description 3 230000023597 hemostasis Effects 0.000 description 3 230000001717 pathogenic Effects 0.000 description 3 230000025627 positiveregulationofurinevolume Effects 0.000 description 3 231100000397 ulcer Toxicity 0.000 description 3 206010000087 Abdominalpainupper Diseases 0.000 description 2 206010002383 Anginapectoris Diseases 0.000 description 2 210000003461 BrachialPlexus Anatomy 0.000 description 2 210000000481 Breast Anatomy 0.000 description 2 206010010774 Constipation Diseases 0.000 description 2 206010011224 Cough Diseases 0.000 description 2 206010012735 Diarrhoea Diseases 0.000 description 2 208000002173 Dizziness Diseases 0.000 description 2 208000001848 Dysentery Diseases 0.000 description 2 208000005171 Dysmenorrhea Diseases 0.000 description 2 206010013935 Dysmenorrhoea Diseases 0.000 description 2 206010019468 Hemiplegia Diseases 0.000 description 2 208000008454 Hyperhidrosis Diseases 0.000 description 2 210000000281 JointCapsule Anatomy 0.000 description 2 210000000214 Mouth Anatomy 0.000 description 2 206010030113 Oedema Diseases 0.000 description 2 210000003800 Pharynx Anatomy 0.000 description 2 231100000614 Poison Toxicity 0.000 description 2 210000003491 Skin Anatomy 0.000 description 2 238000009530 bloodpressuremeasurement Methods 0.000 description 2 210000004889 cervicalnerves Anatomy 0.000 description 2 238000007906 compression Methods 0.000 description 2 238000003745 diagnosis Methods 0.000 description 2 239000000835 fiber Substances 0.000 description 2 201000001881 impotence Diseases 0.000 description 2 230000002757 inflammatory Effects 0.000 description 2 230000002175 menstrual Effects 0.000 description 2 230000000414 obstructive Effects 0.000 description 2 230000000552 rheumatic Effects 0.000 description 2 238000010792 warming Methods 0.000 description 2 208000004998 AbdominalPain Diseases 0.000 description 1 206010063409 Acarodermatitis Diseases 0.000 description 1 206010002156 Analfistula Diseases 0.000 description 1 206010002855 Anxiety Diseases 0.000 description 1 206010057666 Anxietydisease Diseases 0.000 description 1 210000001367 Arteries Anatomy 0.000 description 1 208000006673 Asthma Diseases 0.000 description 1 208000002894 Beriberi Diseases 0.000 description 1 210000001124 BodyFluids Anatomy 0.000 description 1 206010006002 Bonepain Diseases 0.000 description 1 208000001387 Causalgia Diseases 0.000 description 1 206010009346 Clonus Diseases 0.000 description 1 208000002881 Colic Diseases 0.000 description 1 206010051625 Conjunctivalhyperaemia Diseases 0.000 description 1 206010010904 Convulsion Diseases 0.000 description 1 206010011878 Deafness Diseases 0.000 description 1 206010061428 Decreasedappetite Diseases 0.000 description 1 206010013954 Dysphoria Diseases 0.000 description 1 206010013990 Dysuria Diseases 0.000 description 1 208000010228 ErectileDysfunction Diseases 0.000 description 1 210000003754 Fetus Anatomy 0.000 description 1 241000628997 Flos Species 0.000 description 1 206010018836 Haematochezia Diseases 0.000 description 1 206010019847 Hepatosplenomegaly Diseases 0.000 description 1 206010020772 Hypertension Diseases 0.000 description 1 210000003026 Hypopharynx Anatomy 0.000 description 1 206010021118 Hypotonia Diseases 0.000 description 1 206010062717 Increasedupperairwaysecretion Diseases 0.000 description 1 206010061245 Internalinjury Diseases 0.000 description 1 210000000936 Intestines Anatomy 0.000 description 1 206010023126 Jaundice Diseases 0.000 description 1 210000003041 Ligaments Anatomy 0.000 description 1 210000004072 Lung Anatomy 0.000 description 1 206010025482 Malaise Diseases 0.000 description 1 208000002720 Malnutrition Diseases 0.000 description 1 206010026749 Mania Diseases 0.000 description 1 208000007106 Menorrhagia Diseases 0.000 description 1 206010027514 Metrorrhagia Diseases 0.000 description 1 206010028570 Myelopathy Diseases 0.000 description 1 208000008425 ProteinDeficiency Diseases 0.000 description 1 208000003251 Pruritus Diseases 0.000 description 1 208000001431 PsychomotorAgitation Diseases 0.000 description 1 210000004915 Pus Anatomy 0.000 description 1 206010037844 Rash Diseases 0.000 description 1 206010062104 Renalmass Diseases 0.000 description 1 206010038743 Restlessness Diseases 0.000 description 1 208000005687 Scabies Diseases 0.000 description 1 241000447727 Scabies Species 0.000 description 1 206010040872 Skininfection Diseases 0.000 description 1 210000001032 SpinalNerves Anatomy 0.000 description 1 206010061367 Spinalcorddisease Diseases 0.000 description 1 206010042674 Swelling Diseases 0.000 description 1 206010043376 Tetanus Diseases 0.000 description 1 206010044008 Tonsillitis Diseases 0.000 description 1 208000004371 Toothache Diseases 0.000 description 1 210000003462 Veins Anatomy 0.000 description 1 210000001835 Viscera Anatomy 0.000 description 1 206010047601 VitaminB1deficiency Diseases 0.000 description 1 230000003213 activating Effects 0.000 description 1 238000001467 acupuncture Methods 0.000 description 1 230000000202 analgesic Effects 0.000 description 1 230000000146 antalgic Effects 0.000 description 1 230000003110 anti-inflammatory Effects 0.000 description 1 230000001166 anti-perspirant Effects 0.000 description 1 239000003213 antiperspirant Substances 0.000 description 1 230000036506 anxiety Effects 0.000 description 1 238000005452 bending Methods 0.000 description 1 230000002146 bilateral Effects 0.000 description 1 239000010839 bodyfluid Substances 0.000 description 1 239000002775 capsule Substances 0.000 description 1 239000000812 cholinergicantagonist Substances 0.000 description 1 230000001447 compensatory Effects 0.000 description 1 201000009541 complexregionalpainsyndrome Diseases 0.000 description 1 230000036461 convulsion Effects 0.000 description 1 231100000895 deafness Toxicity 0.000 description 1 235000005911 diet Nutrition 0.000 description 1 230000000378 dietary Effects 0.000 description 1 238000002224 dissection Methods 0.000 description 1 230000000857 drugeffect Effects 0.000 description 1 238000002651 drugtherapy Methods 0.000 description 1 229940079593 drugs Drugs 0.000 description 1 230000004064 dysfunction Effects 0.000 description 1 238000005516 engineeringprocess Methods 0.000 description 1 230000001856 erectile Effects 0.000 description 1 230000003419 expectorant Effects 0.000 description 1 239000003172 expectorantagent Substances 0.000 description 1 239000012530 fluid Substances 0.000 description 1 201000005569 gout Diseases 0.000 description 1 238000005469 granulation Methods 0.000 description 1 230000003179 granulation Effects 0.000 description 1 230000001939 inductiveeffect Effects 0.000 description 1 238000002347 injection Methods 0.000 description 1 239000007924 injection Substances 0.000 description 1 210000000629 kneejoint Anatomy 0.000 description 1 230000014759 maintenanceoflocation Effects 0.000 description 1 201000004792 malaria Diseases 0.000 description 1 230000001071 malnutrition Effects 0.000 description 1 235000000824 malnutrition Nutrition 0.000 description 1 238000004519 manufacturingprocess Methods 0.000 description 1 210000004914 menses Anatomy 0.000 description 1 230000005906 menstruation Effects 0.000 description 1 230000027939 micturition Effects 0.000 description 1 239000004084 narcoticanalgesicagent Substances 0.000 description 1 231100000957 nosideeffect Toxicity 0.000 description 1 230000003000 nontoxic Effects 0.000 description 1 231100000252 nontoxic Toxicity 0.000 description 1 231100000862 numbness Toxicity 0.000 description 1 RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemicalcompound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1 230000003119 painkilling Effects 0.000 description 1 244000052769 pathogens Species 0.000 description 1 230000036285 pathologicalchange Effects 0.000 description 1 231100000915 pathologicalchange Toxicity 0.000 description 1 230000000144 pharmacologiceffect Effects 0.000 description 1 239000002574 poison Substances 0.000 description 1 230000001047 pyretic Effects 0.000 description 1 238000011084 recovery Methods 0.000 description 1 230000001105 regulatory Effects 0.000 description 1 230000029058 respiratorygaseousexchange Effects 0.000 description 1 238000009738 saturating Methods 0.000 description 1 230000035807 sensation Effects 0.000 description 1 201000009890 sinusitis Diseases 0.000 description 1 210000004872 softtissue Anatomy 0.000 description 1 230000002048 spasmolytic Effects 0.000 description 1 230000002269 spontaneous Effects 0.000 description 1 230000036262 stenosis Effects 0.000 description 1 200000000009 stenosis Diseases 0.000 description 1 230000035900 sweating Effects 0.000 description 1 201000010874 syndrome Diseases 0.000 description 1 230000035922 thirst Effects 0.000 description 1 239000003440 toxicsubstance Substances 0.000 description 1 238000002604 ultrasonography Methods 0.000 description 1 201000002327 urinarytractobstruction Diseases 0.000 description 1 231100000925 verytoxic Toxicity 0.000 description 1 239000011800 voidmaterial Substances 0.000 description 1 Abstract 本发明公开了一种内服治疗神经根型颈椎病的中药组合物，属中药领域。

该种内服治疗神经根型颈椎病的中药组合物，由黄芪、党参、丹参、葛根、白芍、制川乌、川芎、淫羊藿、桂枝、当归、秦艽、鹿衔草、川加皮、鸡血藤、土鳖虫、何首乌、白芷、海风藤、威灵仙、细辛、香附和地龙按一定重量份制成。

水煎服。

本发明将上述药物组合后，其药效具有协同作用，达到活血通络，补益肝肾，祛风散寒的功效。

该种内服治疗神经根型颈椎病的中药组合物在神经根型颈椎病的治疗中，取得了显著的效果，疗效稳定，缩短治疗时间，无痛苦无毒副作用。

经临床验证有效率94.3％。

Description 一种内服治疗神经根型颈椎病的中药组合物 技术领域 本发明涉及一种内服治疗神经根型颈椎病的中药组合物，属中药领域。

背景技术 神经根型颈椎病是中老年人的常见病，多发病，男多于女，其发病率占各型颈椎病的56.74％。

重体力劳动者较多见。

起病缓慢，有时可因一定程度的损伤诱发；过度低头，长时间低头作业也可诱发。

可单侧发病，也可双侧发病。

它是颈椎侧后方的突出物压迫或刺激颈神经根所引起。

其症状有疼痛，疼痛为绞痛、钝痛或灼痛，颈部功能障碍，影响工作或睡眠。

由于颈部解剖上的特殊，长期负重头颅、运动，且活动范围较大。

当前后伸屈及左右侧旋转、侧弯、旋转头颅运动时，颈椎所受的重应力均在变化，如果颈部姿势不良，长期劳累，则易发生颈部肌肉韧带等软组织劳损；头颈部外伤，或感受风寒湿邪、内伤、颈椎骨关节退行性变、炎症刺激等，导致颈肌痉挛，破坏了颈肌的平衡应力，或颈部活动超出正常范围时，头颅在轻微的外力作用下，就可引起颈椎骨关节旋转、移位，颈椎间盘受到此种外应力的影响，而发生椎间盘退行性变，甚至发生髓核从后方脱出，压迫或刺激脊神经而出现临床症状。

同时也加速颈椎骨关节的病理变化，导致颈椎解剖位置的改变，而发生颈椎失稳，代偿性骨质增生，若压迫或炎症刺激颈神经根则可引起神经根型颈椎病。

神经根型颈椎病的治疗可根据病情轻重、病程长短选择不同治疗方法，其治疗方法繁多，有手法治疗、颈椎牵引治疗、物理治疗、功能治疗、穴位注射治疗针灸治疗、气功治疗、药物治疗、小针刀疗法、饮食疗法和手术治疗等。

以上方法对于治疗神经根型颈椎病有一定的疗效，但不同程度的存在治疗费用高、时间长、见效慢的不足。

发明内容 本发明的目的在于提供一种内服治疗神经根型颈椎病的中药组合物，全部选用天然中草药，能够有效治疗神经根型颈椎病。

本发明的技术方案是：该种内服治疗神经根型颈椎病的中药组合物，其特征在于，制成有效成分的原料药按下述重量份为：黄芪20、党参10、丹参10、葛根20、白芍15、制川乌12、川芎10、淫羊藿10、桂枝10、当归12、秦艽15、鹿衔草12、川加皮15、鸡血藤30、土鳖虫12、何首乌25、白芷12、海风藤10、威灵仙20、细辛3、香附10和地龙8。

用法：水煎服，日服1剂。

15天为一疗程。

药理作用：黄芪：补气升阳，补气摄血，补气行滞，去瘀散结，益气固表，补气益阴，利水消肿，温里散寒，托脓生肌，强体质，延年益寿。

白芷：祛风，燥湿，消肿，止痛。

治头痛，眉棱骨痛，齿痛，鼻渊，寒湿腹痛，肠风痔漏，赤白带下，痈疽疮疡，皮肤燥痒，疥癣。

制川乌：辛、苦，热；有大毒。

归心、肝、肾、脾经。

祛风除湿，温经止痛。

用于风寒湿痹，关节疼痛，心腹冷痛，寒疝作痛，麻醉止痛。

白芍：养血柔肝，缓中止痛，敛阴收汗。

治胸腹胁肋疼痛，泻痢腹痛，自汗盗汗，阴虚发热，月经不调，崩漏，带下。

葛根：治伤寒、温热头痛项强，烦热消渴，泄泻，痢疾，癍疹不透，高血压，心绞痛，耳聋。

川芎：气开郁，祛风燥湿，活血止痛。

治风冷头痛，旋晕，胁痛腹疼，寒痹筋挛，经闭，难产，产后瘀阻块痛，痈疽疮疡。

淫羊藿：补肾壮阳，祛风除湿。

治阳痿不举，小便淋沥，筋骨挛急，半身不遂，腰膝无力，风湿痈痛，四肢不仁。

桂枝：发汗解肌，温通经脉，助阳化气，平冲降气。

用于风寒感冒，脘腹冷痛，血寒经闭，关节痹痛，痰饮，水肿，心悸，奔豚。

秦艽：祛风除湿，和血舒筋，清热利尿。

治风湿痹痛；筋骨拘挛，黄疸，便血，骨蒸潮热，小儿疳热，小便不利。

当归：补血活血，调经止痛，润肠通便。

用于血虚萎黄，眩晕心悸，月经不调，经闭痛经，虚寒腹痛，肠燥便秘，风湿痹痛，跌扑损伤，痈疽疮疡。

鹿衔草：甘、苦，温。

归肝、肾经。

祛风湿，强筋骨，止血。

用于风湿痹痛，腰膝无力，月经过多，久咳劳嗽。

鸡血藤：活血化瘀，其性温，味苦、甘，归肝、肾经。

有补血、活血、通络的功效。

何首乌：补肝，益肾，养血，祛风。

治肝肾阴亏，发须早白，血虚头晕，腰膝软弱。

川加皮：性温，味辛，无毒。

入肝、肾经。

祛风湿，通关节，强筋骨。

治痿痹，拘挛疼痛，风寒湿痹，足膝无力，皮肤风湿及阴痿囊湿。

土鳖虫：性寒，有微毒。

具有化淤止血，消肿止痛，通络理伤，接筋续骨的功效。

海风藤：辛、苦，微温。

归肝经。

祛风湿，通经络，止痹痛。

用于风寒湿痹，肢节疼痛，筋脉拘挛，屈伸不利。

丹参：祛瘀止痛，活血通经，清心除烦。

用于月经不调、经闭痛经、症瘕积聚、胸腹刺痛、热痹疼痛、疮疡肿痛、肝脾肿大、心绞痛。

党参：补中益气，健脾生津。

用于脾肺虚弱、气短心悸、食少便溏，四肢倦怠。

红花：活血通经，去瘀止痛。

治经闭，难产，死胎，产后恶露不行、瘀血作痛，痈肿，跌扑损伤。

香附：辛、微苦、甘、平。

归肝、三焦经。

疏肝益气，活血调经。

地龙：咸寒。

清热，镇痉，利尿，解毒。

治热病惊狂、小儿惊风、咳喘、头痛目赤、咽喉肿痛、小便不通、风湿关节疼痛，半身不遂等症。

细辛：具有散寒解表、祛风除湿、活血化瘀、消炎止痛、清热解毒等功效。

威灵仙：风湿，通经络，消痰涎，散癖积。

治痛风、顽痹、腰膝冷痛、脚气、疟疾、症瘕积聚、破伤风、扁桃体炎、诸骨鲠咽。

本发明将上述药物组合后，其药效具有协同作用，达到活血通络，补益肝肾，祛风散寒的功效。

该种内服治疗神经根型颈椎病的中药组合物在神经根型颈椎病的治疗中，取得了显著的效果，疗效稳定，缩短治疗时间，无痛苦无毒副作用。

经临床验证有效率94.3％。

典型病例：例1：苏某，男，52岁，后颈部及右上臂疼痛5年半，加重20天。

病人曾作颈椎牵引治疗无明显疗效，无外伤史。

检查发现后颈部肌肉较紧张，颈4棘突右旋移位，右侧颈3～4关节囊肿胀，压痛明显。

颈功能受限，压颈试验阳性，臂丛牵拉试验阳性。

后颈部、右肩及臂、手指麻胀疼痛。

X线片示：颈椎生理曲度变直，颈4～6呈退行性病变，颈3～4、颈4～5椎间隙变窄，后关节稍模糊，椎体前后缘骨质增生，颈4棘突向右偏移并椎体稍后移。

B超检查：颈椎管正常。

诊断为神经根型颈椎病，中医辨证血瘀气滞型颈项痛(痛痹)。

采用该种内服治疗神经根型颈椎病的中药组合物治疗三天后，疼痛减轻，继续治疗一个月后痊愈。

例2：曾某，男，67岁，病人在6年前跌伤颈部治愈，3个月后因劳累自觉后颈胀痛，运动颈部后症状减轻。

近1个月来后颈及左肩臂、手指麻胀疼痛加剧。

检查发现：后颈部肌肉较紧张，颈6-7棘突左旋移位，左侧颈3-4关节囊肿胀，压痛明显。

压颈试验阳性，臂丛牵拉试验阳性，颈功能受限。

X线片示(31945)：颈椎后缘骨质增生，颈3椎体旋转后移4毫米，颈6、7棘突陈旧性骨折，对位欠佳，颈2-3椎间隙狭窄。

西医诊断为神经根型颈椎病。

中医诊断为血瘀气滞型颈项痛，兼地肾亏虚。

给与该种内服治疗神经根型颈椎病的中药组合物活血通络，补益肝肾，祛风散寒。

两个疗程后痊愈。

具体实施方式 例一：一种内服治疗神经根型颈椎病的中药组合物，制成有效成分的原料药按下述重量份为：黄芪20、党参10、丹参10、葛根20、白芍15、制川乌12、川芎10、淫羊藿10、桂枝10、当归12、秦艽15、鹿衔草12、川加皮15、鸡血藤30、土鳖虫12、何首乌25、白芷12、海风藤10、威灵仙20、细辛3、香附10和地龙8。

用法：水煎服，日服1剂。

15天为一疗程。

Claims(1) 1.一种内服治疗神经根型颈椎病的中药组合物，其特征在于，制成有效成分的原料药按下述重量份为：黄芪20、党参10、丹参10、葛根20、白芍15、制川乌12、川芎10、淫羊藿10、桂枝10、当归12、秦艽15、鹿衔草12、川加皮15、鸡血藤30、土鳖虫12、何首乌25、白芷12、海风藤10、威灵仙20、细辛3、香附10和地龙8。

CN200710014557A 2007-04-19 2007-04-19 一种内服治疗神经根型颈椎病的中药组合物 Expired-FeeRelated CN100594033C (zh) PriorityApplications(1) ApplicationNumber PriorityDate FilingDate Title CN200710014557A CN100594033C (zh) 2007-04-19 2007-04-19 一种内服治疗神经根型颈椎病的中药组合物 ApplicationsClaimingPriority(1) ApplicationNumber PriorityDate FilingDate Title CN200710014557A CN100594033C (zh) 2007-04-19 2007-04-19 一种内服治疗神经根型颈椎病的中药组合物 Publications(2) PublicationNumber PublicationDate CN101040981A true CN101040981A (zh) 2007-09-26 CN100594033C CN100594033C (zh) 2010-03-17 Family ID=38806910 FamilyApplications(1) ApplicationNumber Title PriorityDate FilingDate CN200710014557A Expired-FeeRelated CN100594033C (zh) 2007-04-19 2007-04-19 一种内服治疗神经根型颈椎病的中药组合物 CountryStatus(1) Country Link CN (1) CN100594033C (zh) CitedBy(5) *Citedbyexaminer,†Citedbythirdparty Publicationnumber Prioritydate Publicationdate Assignee Title CN101912539A (zh) * 2010-08-20 2010-12-15 安徽精方药业股份有限公司 一种用于治疗神经根型颈椎病的中药组合物及其制备方法 CN102920879A (zh) * 2012-11-21 2013-02-13 王云 一种治疗颈椎病的中药组合物 CN103239588A (zh) * 2013-05-10 2013-08-14 山东省中医药研究院 一种治疗颈椎病的中药组合物 CN104587225A (zh) * 2015-01-14 2015-05-06 姜丽莎 一种治疗颈椎病的中药组合物 CN106511905A (zh) * 2016-12-20 2017-03-22 广州聚澜健康产业研究院有限公司 一种用于治疗颈椎病的中药制剂及其制备方法 2007 2007-04-19 CN CN200710014557A patent/CN100594033C/zh not_active Expired-FeeRelated CitedBy(7) *Citedbyexaminer,†Citedbythirdparty Publicationnumber Prioritydate Publicationdate Assignee Title CN101912539A (zh) * 2010-08-20 2010-12-15 安徽精方药业股份有限公司 一种用于治疗神经根型颈椎病的中药组合物及其制备方法 CN101912539B (zh) * 2010-08-20 2012-08-01 安徽精方药业股份有限公司 一种用于治疗神经根型颈椎病的中药组合物及其制备方法 CN102920879A (zh) * 2012-11-21 2013-02-13 王云 一种治疗颈椎病的中药组合物 CN103239588A (zh) * 2013-05-10 2013-08-14 山东省中医药研究院 一种治疗颈椎病的中药组合物 CN103239588B (zh) * 2013-05-10 2014-07-02 山东省中医药研究院 一种治疗颈椎病的中药组合物 CN104587225A (zh) * 2015-01-14 2015-05-06 姜丽莎 一种治疗颈椎病的中药组合物 CN106511905A (zh) * 2016-12-20 2017-03-22 广州聚澜健康产业研究院有限公司 一种用于治疗颈椎病的中药制剂及其制备方法 AlsoPublishedAs Publicationnumber Publicationdate CN100594033C (zh) 2010-03-17 SimilarDocuments Publication PublicationDate Title CN101926961B (zh) 2011-11-16 一种内服治疗盆腔炎的中药组合物 CN101040978A (zh) 2007-09-26 一种内服治疗颈椎病的中药组合物 CN100594033C (zh) 2010-03-17 一种内服治疗神经根型颈椎病的中药组合物 CN100393353C (zh) 2008-06-11 一种治疗风湿痹痛的药酒 CN100998656A (zh) 2007-07-18 壮骨通络酒 CN101040930B (zh) 2010-10-13 一种外用治疗腰椎间盘突出的中药组合物 CN102247497A (zh) 2011-11-23 一种治疗类风湿性关节炎的中成药 CN102225108A (zh) 2011-10-26 治疗腰痛、腰椎间盘突出的药酒 CN103263601B (zh) 2015-01-07 一种加速骨折手术后愈合速度的中药制剂及制备方法 CN103446360B (zh) 2015-03-25 治疗腰椎间盘突出的中药胶囊制剂及其制备方法 CN103735756A (zh) 2014-04-23 一种治疗腰腿疼痛的中药配方 CN103202985A (zh) 2013-07-17 治疗腰椎、颈椎、坐骨神经、风湿病的中药及其制备方法 CN101036706A (zh) 2007-09-19 活血化淤舒筋通络祛风湿酒 CN102579672A (zh) 2012-07-18 一种治疗骨质增生和腰椎间盘突出的药物 CN105497856A (zh) 2016-04-20 用于化疗引起的末梢神经损伤导致的肢端麻痹的中药 CN105412626A (zh) 2016-03-23 一种用于治疗颈椎骨质增生的药物制剂及其用途 CN1076619C (zh) 2001-12-26 配合穴位治疗的灸药 CN104524080A (zh) 2015-04-22 主治跌打损伤中药剂及制备方法 CN102441131A (zh) 2012-05-09 一种治疗跌打损伤的中药组合物 CN104398664A (zh) 2015-03-11 一种治疗排卵障碍性不孕症的壮药组合物 CN104352969A (zh) 2015-02-18 一种治疗脑出血后遗症的药物 CN104258285A (zh) 2015-01-07 一种内服外用治疗腰椎骨质增生的药物及其制备方法 CN101040926B (zh) 2010-05-26 一种内服治疗颈型颈椎病的中药组合物 CN101040986B (zh) 2010-06-23 一种内服治疗神经根型颈椎病的中药组合物 CN101468095A (zh) 2009-07-01 一种治疗腰椎间盘突出的药物组合物 LegalEvents Date Code Title Description 2007-09-26 C06 Publication 2007-09-26 PB01 Publication 2007-11-21 C10 Entryintosubstantiveexamination 2007-11-21 SE01 Entryintoforceofrequestforsubstantiveexamination 2010-03-17 C14 Grantofpatentorutilitymodel 2010-03-17 GR01 Patentgrant 2011-06-22 C17 Cessationofpatentright 2011-06-22 CF01 Terminationofpatentrightduetonon-paymentofannualfee Grantedpublicationdate: 20100317 Terminationdate: 20100419